Evidence map›Paper›PMID 28926602›Full record

ArticlePloS one2017

Autoimmune disease mouse model exhibits pulmonary arterial hypertension.

Koichi Sugimoto, Kazuhiko Nakazato, Akihiko Sato, Satoshi Suzuki, Akiomi Yoshihisa, Takeshi Machida, Shu-Ichi Saitoh, Hideharu Sekine, Yasuchika Takeishi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. The Levels of TNF-Computational and mathematical methods in medicine · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2020
    Article
  8. Endothelins in inflammatory neurological diseases.Pharmacology & therapeutics · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Koichi SugimotoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.ORCID http://orcid.org/0000-0002-7527-7288
Kazuhiko NakazatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Akihiko SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi SuzukiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Akiomi YoshihisaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takeshi MachidaDepartment of Immunology, Fukushima Medical University, Fukushima, Japan.
Shu-Ichi SaitohDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Hideharu SekineDepartment of Immunology, Fukushima Medical University, Fukushima, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary arterial hypertension is often associated with connective tissue disease. Although there are some animal models of pulmonary hypertension, an autoimmune disease-based model has not yet been reported. MRL/lpr mice, which have hypergammaglobulinemia, produce various autoimmune antibodies, and develop vasculitis and nephritis spontaneously. However, little is known about pulmonary circulation in these mice. In the present study, we examined the pulmonary arterial pressure in MRL/lpr mice. METHODS AND

resultsWe used female MRL/lpr mice aged between 12 and 14 weeks. Fluorescent immunostaining showed that there was no deposition of immunoglobulin or C3 in the lung tissue of the MRL/lpr mice. Elevation of interferon-γ and interleukin-6 was recognized in the lung tissue of the MRL/lpr mice. Right ventricular systolic pressure, Fulton index and the ratio of right ventricular weight to body weight in the MRL/lpr mice were significantly higher than those in wild type mice with same background (C57BL/6). The medial smooth muscle area and the proportion of muscularized vessels in the lung tissue of the MRL/lpr mice were larger than those of the C57BL/6 mice. Western blot analysis demonstrated markedly elevated levels of prepro-endothelin-1 and survivin as well as decreased endothelial nitric oxide synthase phosphorylation in the lung tissue of the MRL/lpr mice. Terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling assay showed the resistance against apoptosis of pulmonary arterial smooth muscle cells in the MRL/lpr mice.

conclusionWe showed that MRL/lpr mice were complicated with pulmonary hypertension. MRL/lpr mice appeared to be a useful model for studying the mechanism of pulmonary hypertension associated with connective tissue diseases.

Indexed as

AnimalsApoptosisAutoimmune DiseasesBlood PressureComplement C3CytokinesDisease Models, AnimalEndothelin-1Heart VentriclesHypertension, PulmonaryImmunoglobulin GInhibitor of Apoptosis ProteinsLungMiceMice, Inbred C57BLMice, Inbred MRL lprBirc5 protein, mouseComplement C3CytokinesEndothelin-1Immunoglobulin GInhibitor of Apoptosis ProteinsNitric Oxide Synthase Type IIIRepressor ProteinsSurvivin

Identifiers

PMID28926602
PMCPMC5605000
OpenAlexW2755901052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.